Related Experiment Video
Updated: Oct 10, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
RNF12 Promotes Glioblastoma Malignant Proliferation via Destructing RB1 and Regulating MAPK Pathway
1Zhenjiang First People's Hospital, Zhenjiang, China.
Background:
RNF12 has been linked to a variety of biological activities, including the control of the MDM2/P53 pathway, although its additional functions remain unclear. RNF12 was discovered to be a new ubiquitin ligase (E3) for RB1, amongst the most frequently repressed proteins in cancer of human.
Method:
Cell Counting Kit-8 was used to detect the cell proliferation; coimmunoprecipitation was used to determine that RNF12 interacts with RB1. Xenograft studies were used to verify the results.
Result:
In vivo and in vitro RNF12 interacts with RB1 regardless of E3 ligase activity. The ubiquitination of RB1 by RNF12 had an effect on its stability. RNF12 inhibits the RB1 protein and stimulates the MAPK pathway, promoting the growth of GBMs.
Conclusion:
Our findings show that RNF12 may operate as a tumour promoter by modulating the cancerous proliferation of glioblastoma by controlling the activity of a new RNF12/RB1/MAPK pathway regulatory axis and that this regulatory axis might be a valuable diagnostic focus in glioblastoma.
Insights
RNF12 ubiquitin ligase targets RB1, promoting glioblastoma growth by activating the MAPK pathway. This RNF12/RB1/MAPK axis offers a potential diagnostic target for glioblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- RNF12 (Ring Finger 12) is implicated in various biological processes, including MDM2/P53 pathway regulation.
- RNF12 is identified as a novel E3 ubiquitin ligase for RB1 (Retinoblastoma protein 1), a frequently downregulated protein in human cancers.
Purpose of the Study:
- To investigate the functional interaction between RNF12 and RB1.
- To elucidate the role of RNF12 in glioblastoma multiforme (GBM) pathogenesis.
Main Methods:
- Cell Counting Kit-8 assay for cell proliferation.
- Coimmunoprecipitation to confirm RNF12-RB1 interaction.
- In vivo xenograft studies for validation.
Main Results:
- RNF12 interacts with RB1 both in vitro and in vivo, independent of its E3 ligase activity.
- Ubiquitination of RB1 by RNF12 impacts its protein stability.
- RNF12 inhibits RB1 and stimulates the MAPK pathway, driving GBM growth.
Conclusions:
- RNF12 acts as a tumor promoter in glioblastoma by regulating cancer cell proliferation.
- The novel RNF12/RB1/MAPK pathway axis is crucial for GBM development.
- This regulatory axis presents a potential diagnostic target for glioblastoma.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
The Ras Gene
Ras is a...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

